Denise Pollard-Knight

Affiliations

  • Chief Executive Officer at Mereo Biopharma Group Plc (MREO), 2024-09-17
  • at Elanco Animal Health Inc (ELAN), 2023-12-04
  • Director at Oncomed Pharmaceuticals Inc (OMED), 2018-06-25
  • Large Shareholder, Director at Albireo Pharma Inc. (ALBO), 2017-06-20
  • Director at Idenix Pharmaceuticals Inc (IDIX), 2014-08-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OMED $17.00 58,824 Director 2,122,807 2013-07-23 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MREO $4.22 60,046 808,921 2024-09-13 Filing
MREO $4.47 28,611 868,967 2024-09-12 Filing
MREO $3.39 92,273 709,518 2024-06-26 Filing
MREO $3.69 40,712 801,791 2024-06-25 Filing
OMED $21.66 3,799 Director 1,943,509 2014-12-31 Filing